Alberta Precision Laboratories

--- Query Results ---

Organization:

Alberta Precision Laboratories

Message Alert:

PLEASE NOTE: This Test Directory is in an interim state and due to changes pertaining to the DynaLIFE transition, performing site for routing has not been updated. Please refer to Laboratory Information System for appropriate routing.

Test Name/Synonym:

Glucose Tolerance, Pregnant
Glucose Tolerance, Non-Pregnant- Calgary Zone

Primary Container:

Lithium Heparin PST Gel (Light Green)

Specimen Collection Requirements:

This test requires collection of a fasting blood specimen, followed by collection of several blood specimens after the patient is given a glucose drink.
The concentration of glucose in the drink is dependent on the patient's weight.
The procedure takes 2 or more hours.

Breastfeeding during the glucose tolerance test may moderately impact glucose results.
It is recommended, but not required, to avoid or minimize breastfeeding during the glucose tolerance test.

Test cannot be collected by Mobile Collection Service (MCS).

By appointment only:
Community patients: Contact APL Patient Appointment Line at 403-777-5136 to book an appointment at any Patient Service Centre.

Patients less than 18 years of age will be required to provide their body weight.
Patients weighing less than 42 kg (92 pounds) must be referred to the Glenbrook Patient Service Center with advanced notice given to the site. The tests are performed Monday to Friday.

Hospital patients: Nursing unit to book appointment with on-site lab.

Calgary Zone staff:
Refer to PX-SC740 Timed Interval Tests for instructions.

Glucose drink is administered and specimens collected ONLY IF fasting glucose result meets criteria defined below:
Site	GTTP	GTTNP
CRL and RRL	Less than or equal to 5.2 mmol/L	Less than or equal to 7.8 mmol/L
PSC	Less than or equal to 5.9 mmol/L	Less than or equal to 7.8 mmol/L

Administer drink regardless of fasting glucose IF 'Give glucose drink regardless of fasting glucose' is written on the requisition.
Clinicians may do this for certain patients, e.g. mother at high risk of GDM or early in pregnancy (< 20 weeks gestation).

Each collection requires:
One .3 mL or 4.5 mL light green (mint) PST tube. Gold top SST tube also acceptable.
0.2 mL plasma or serum.

Calgary Zone: Microcollection Minimum Whole Blood Volumes
Patient MUST be Fasting Tests a minimum of 8 hours, but not more than 16 hours.

Testing Schedule:

Test performed Monday to Friday

Reference Interval:

Fasting Specimen

Age	Reference Interval
0 up to 72 hours	2.6 – 5.5 mmol/L
72 hours up to unspecified	3.3 - 6.0 mmol/L

Interpretation

Non-Pregnant Adults and Children

Diagnosis of Diabetes Mellitus	Fasting Plasma glucose 7.0 mmol/L or greater OR Plasma glucose 2 hours post administration of the 75 g glucose drink 11.1 mmol/L or greater
Diagnosis of impaired fasting glucose (Prediabetes)	Fasting plasma glucose of 6.1 mmol/L up to and including 6.9 mmol/L; AND Plasma glucose 2 hours post administration of the 75 g glucose drink of less than 7.8 mmol/L
Diagnosis of impaired glucose tolerance (Prediabetes)	Fasting plasma glucose less than 6.1 mmol/L; AND Plasma glucose 2 hours post administration of the 75 g glucose drink of 7.8 mmol/L up to and including 11.0 mmol/L
Diagnosis of impaired fasting glucose and impaired glucose tolerance (Prediabetes)	Fasting plasma glucose of 6.1 mmol/L up to and including 6.9 mmol/L AND Plasma glucose 2 hours post administration of the 75 g glucose drink of 7.8 mmol/L up to and including 11.0 mmol/L

Pregnant patients:
Note: The 75 g Oral Glucose Tolerance Test for GDM should be performed if the Gestational Diabetes Screen result is 7.8 mmol/L up to and including 11.0 mmol/L.

Diagnosis of Gestational Diabetes Mellitus

GDM is diagnosed if one or more of the following three values are elevated during the 75 g Oral Glucose Tolerance Test:

Fasting plasma glucose 5.3 mmol/L or greater

Plasma glucose 1 hour post administration of glucose drink of 10.6 mmol/L or greater

Plasma glucose 2 hours post administration of glucose drink of 9.0 mmol/L or greater

Hypoglycemia:

Documentation of reactive hypoglycemia requires demonstration of Whipple’s Triad:

Symptoms
Alleviation by glucose
Plasma glucose less than 4.0 mmol/L for patients treated with insulin or an insulin secretagogue

Severe hypoglycemia is typically defined at plasma glucose levels less than 2.8 mmol/L.

Testing Area:

Chemistry

Performing Site:

Chemistry-ACH, DSC, FMC, PLC, RGH, SHC
Rural: CRL

Additional Test Information:

Patient instruction sheet (form CH3002) may be given to patient.

The drink provided for this test includes the following ingredients:

Flavoured Drink		Unflavoured Drink
Patient Service Centre and Calgary Hospital Sites Dextrose/Glucose (derived from corn) Citric acid Artificial flavours Sodium benzoate FD&C Yellow #6 Purified water	Calgary Rural Lab Sites Dextrose/Glucose (derived from corn) Citric acid Natural orange flavouring Sodium benzoate FD&C Yellow #6 FD&C Red #40 Purified water	All Sites Dextrose/Glucose (derived from corn) Potassium sorbate (0.2%) Purified water

For non-pregnant patients:
The test consists of a fasting glucose and a 2 hour collection.

For pregnant patients:
The Glucose Tolerance Test for Gestational Diabetes Mellitus (GDM) consists of a fasting blood sample, as well as samples collected at 1 hour and 2 hours after consuming a glucose drink.
The glucose drink is not given if the fasting glucose result is high enough to suggest GDM.

Write 'Give glucose drink regardless of fasting glucose' on the requisition if you wish to override this procedure, e.g. mother at high risk of GDM or early in pregnancy (< 20 weeks gestation).

Pregnant patients being tested for GDM should first undergo the Gestational Diabetes Screen.
If the screen result is between 7.8 mmol/L up to and including 11.0 mmol/L, then the Glucose Tolerance Test is warranted.
Screen results of 11.1 mmol/L or greater are diagnostic of GDM; therefore a glucose tolerance test is not needed.

For Diabetes Clinical Practice Guidelines, please see: Canadian Diabetes Association Clinical Practice Guidelines.

Note: This test should not be performed at or after 35 weeks of gestation. Fasting blood glucose and/or Hemoglobin A1c (HbA1c) are the recommended tests at or after 35 weeks gestation. Please click here for further information.

Last Updated On:

Wednesday, September 4, 2024